Latest News in the pharma Industry

Policy & Regulation

US Marshals Seize Unapproved Drugs from Ohio Distributor

US Marshals Seize Unapproved Drugs from Ohio Distributor

20 May 2014

Read more 
Novartis Settles Patent Litigation on Gleevec (Imatinib Mesylate) with Sun Pharma Subsidiary

Novartis Settles Patent Litigation on Gleevec (Imatinib Mesylate) with Sun Pharma Subsidiary

15 May 2014

Read more 
Investigational PD-1 Immune Checkpoint Inhibitor Nivolumab Receives U.S. FDA Breakthrough Therapy Designation for Hodgkin Lymphoma

Investigational PD-1 Immune Checkpoint Inhibitor Nivolumab Receives U.S. FDA Breakthrough Therapy Designation for Hodgkin Lymphoma

15 May 2014

Read more 
Health Canada Confirms License Suspension of Biolyse Pharma for Serious Manufacturing Concerns

Health Canada Confirms License Suspension of Biolyse Pharma for Serious Manufacturing Concerns

14 May 2014

Read more 
NICE Issues Positive Recommendation for Xtandi  (Enzalutamide)

NICE Issues Positive Recommendation for Xtandi (Enzalutamide)

9 May 2014

Read more 
CDER SBIA Webinar on Postapproval Changes that may be Documented in Annual Reports

CDER SBIA Webinar on Postapproval Changes that may be Documented in Annual Reports

7 May 2014

Read more 
FDA Approves Epanova for the Treatment of Adults with Severe Hypertriglyceridaemia

FDA Approves Epanova for the Treatment of Adults with Severe Hypertriglyceridaemia

6 May 2014

Read more 
Epigenomics Updates on Regulatory Status for Epi proColon in the USA

Epigenomics Updates on Regulatory Status for Epi proColon in the USA

29 Apr 2014

Read more 
Lilly's Cyramza (Ramucirumab) Becomes First FDA-Approved Treatment for Advanced Gastric Cancer After Prior Chemotherapy

Lilly's Cyramza (Ramucirumab) Becomes First FDA-Approved Treatment for Advanced Gastric Cancer After Prior Chemotherapy

23 Apr 2014

Read more 
FDA Approves Merck’s Ragwitek (Short Ragweed Pollen Allergen Extract) Sublingual Tablet

FDA Approves Merck’s Ragwitek (Short Ragweed Pollen Allergen Extract) Sublingual Tablet

18 Apr 2014

Read more 
European Medicines Agency Alerts EU Healthcare Professionals After Vials of Falsified Herceptin Identified

European Medicines Agency Alerts EU Healthcare Professionals After Vials of Falsified Herceptin Identified

17 Apr 2014

Read more 
Boehringer Ingelheim and Eli Lilly and Company Announce NDA Filing in the US for the Combination Tablet of Empagliflozin and Linagliptin

Boehringer Ingelheim and Eli Lilly and Company Announce NDA Filing in the US for the Combination Tablet of Empagliflozin and Linagliptin

16 Apr 2014

Read more